04.02.2014 • NewsDede WillamsCMIDaiichi Sankyo

Daiichi Sankyo Pledges “Bold Action” on Ranbaxy Ban

Japan's Daiichi Sankyo said it would send personnel to help resolve problems at a production facility of its drugmaking subsidiary Ranbaxy at Toansa in India's northern state of Punjab. The U.S. Food and Drug Administration has banned exports from the plants due to manufacturing violations. It is the fourth Ranbaxy plant to be shut out of the U.S. market.
Manabu Sakai, senior executive officer at Daiichi Sankyo, told an earnings briefing that the company wants to prepare "a more aggressive, more drastic response" to the ban.

Following an inspection completed on Jan. 11, the FDA said in late January that Ranbaxy is prohibited from making and selling pharmaceutical ingredients from Toansa "to prevent substandard quality products from reaching U.S. consumers."

The U.S. regulator had previously barred products from the company's facilities in Paonta Sahib, Dewas and Mohali in India as part of a 2012 consent decree designed to ensure compliance with good manufacturing practices.

At the Toansa facility the FDA said it found that Ranbaxy had re-tested raw materials and other ingredients after the items failed analytical testing in order to produce acceptable findings, but the company did not report or investigate the failures.

Whitepaper

Cannabis Extraction — Temperature Control Systems in Action

Cannabis Extraction — Temperature Control Systems in Action

Cannabis is a crop that has been cultivated for thousands of years and contains many pharmacologically active substances.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Photo
15.01.2025 • News

Global Outlook on Bio-based Polymers

It is important to examine the current state of bio-based polymers. This includes the rapidly growing production capacity, significant investments currently underway in China, Europe, and the Middle East, and the new political conditions in Europe that are driving demand for biodegradable polymers.